Display options
Cite
Akaogi J, Yotsuyanagi H, Sugata F, et al. Hepatitis viral infection in Behçet's disease. Hepatol Res. 2000;17(2):126-138doi: 10.1016/s1386-6346(99)00070-4.
Akaogi, J., Yotsuyanagi, H., Sugata, F., Matsuda, T., & Hino, K. (2000). Hepatitis viral infection in Behçet's disease. Hepatology research : the official journal of the Japan Society of Hepatology, 17(2), 126-138. https://doi.org/10.1016/s1386-6346(99)00070-4
Akaogi, et al. "Hepatitis viral infection in Behçet's disease." Hepatology research : the official journal of the Japan Society of Hepatology vol. 17,2 (2000): 126-138. doi: https://doi.org/10.1016/s1386-6346(99)00070-4
Akaogi J, Yotsuyanagi H, Sugata F, Matsuda T, Hino K. Hepatitis viral infection in Behçet's disease. Hepatol Res. 2000 May;17(2):126-138. doi: 10.1016/s1386-6346(99)00070-4. PMID: 10707006.
Copy Download .nbib Format: NLM
Share it on

Hepatol Res. 2000 May;17(2):126-138. doi: 10.1016/s1386-6346(99)00070-4.

Hepatitis viral infection in Behçet's disease.

Hepatology research : the official journal of the Japan Society of Hepatology

Akaogi, Yotsuyanagi, Sugata, Matsuda, Hino

Affiliations

  1. Department of Internal Medicine, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki, Japan

PMID: 10707006 DOI: 10.1016/s1386-6346(99)00070-4

Abstract

To elucidate the role of hepatitis viruses in the pathogenesis of Behçet's disease (BD), we measured hepatitis viral markers (anti-hepatitis A (anti-HA), HBsAg, anti-HBs, anti-HBc) and viral nucleic acids (hepatitis B virus (HBV)-DNA, hepatitis C virus (HCV)-RNA, GB virus C (GBV-C)-RNA, TT virus (TTV)-DNA) in the sera of 68 BD patients along with 76 blood donors matched for age and sex. Positivity of anti-HA in patients with BD (36.8%) was lower than that in blood donors (68.0%). Both anti-HCV and HCV-RNA were detected in only one (1.5%) patient with BD and in none of the blood donors. The prevalence ratios of HBsAg, anti-HBs, anti-HBc in both groups were similar (2.9:0, 16.2:15.8 and 17.7:19.7%, respectively). However, serum HBV-DNA was detected more frequently in BD patients (8/68; 11.8%) than in blood donors (2/76; 2.6%) (P<0.05). The prevalence of GBV-C-RNA was also higher in patients with BD (4/68; 5.9%) compared with blood donors (0%). However, characteristics and clinical features are similar between GBV-C-RNA-positive and -negative groups. With respect to the prevalence of TTV-DNA, there was no significant difference between BD patients (23.5%) and blood donors (30.3%). Our study indicates that HBV and GBV-C infection might be related to BD, although the role of these viruses remains to be investigated.

Publication Types